KRAS and colorectal cancer: In a comprehensive analysis of advanced colorectal cancer and an evaluation of the concordance rate of a few driver mutations between primary and metastatic lesions, a concordance rate of approximately 95% was found when focusing on KRAS and BRAF hot point mutations.39